Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Treasury Shares (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Treasury Shares for 5 consecutive years, with $20.3 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Treasury Shares fell 71.55% year-over-year to $20.3 million, compared with a TTM value of $20.3 million through Jun 2025, down 71.55%, and an annual FY2025 reading of $348527.0, down 93.57% over the prior year.
  • Treasury Shares was $20.3 million for Q2 2025 at Roivant Sciences, up from $348527.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $71.3 million in Q2 2024 and bottomed at $348527.0 in Q1 2025.
  • Average Treasury Shares over 5 years is $11.8 million, with a median of $4.4 million recorded in 2022.
  • The sharpest move saw Treasury Shares surged 2387.32% in 2024, then tumbled 93.57% in 2025.
  • Year by year, Treasury Shares stood at $22.6 million in 2021, then dropped by 1.92% to $22.2 million in 2022, then tumbled by 90.35% to $2.1 million in 2023, then tumbled by 66.8% to $710060.0 in 2024, then surged by 2754.61% to $20.3 million in 2025.
  • Business Quant data shows Treasury Shares for ROIV at $20.3 million in Q2 2025, $348527.0 in Q1 2025, and $710060.0 in Q4 2024.